DR Systems, a leading independent provider of enterprise-wide medical imaging and information systems, announced that the United States Patent and Trademark Office (USPTO) has issued to the company a new patent, relating to a system and method for viewing medical images at full resolution.

Advanced Radiation Therapy (ART), manufacturer of the AccuBoost System for radiation therapy of partial breast and Elekta a global leader in cancer management systems and software, announced today that they have executed an agreement whereby ART acquires the assets of all AccuBoost installations held by Elekta, its worldwide distribution partner. As part of the transaction, ART has purchased the assets and the operating agreements for more than 20 installations in the U.S. The transaction is designed to enable both companies to focus on their core competencies, and serves AccuBoost user groups by allowing ART to increase its support to these installations.

Viztek, the advanced digital imaging solution provider, has received United States Federal Food and Drug Administration (FDA) 510k clearance for the ViZion + DR line of panels. This new family of products includes multiple panels in tethered, wireless and fixed configurations offering high quality images at quick speeds, while remaining at a competitive price point. Unlike many competing products, the panels have an ease of adaptability and require no generator interface.

Embrace Thermoplastic is a premium low-melt material used to create customizable immobilization for patients receiving radiation therapy treatments of the head and neck. Embrace Thermoplastic products include Standard UFrames, Versaboard frames, S-Type frames, and Thermoplastic sheets. All Embrace Thermoplastic products are made in the United States.

U.S. Imaging Equipment Servicing Market Millenium Market Research Group

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the U.S. market for diagnostic imaging equipment servicing will grow slowly to a value of just over $2.78 billion by 2017. Increases in diagnostic imaging system sales and the installed base will be counterbal
Hologic Inc. Radiology RSNA 3-D Mammography Clinical Study

http://glossary.itnonline.com/3d-mammographyHologic Inc. announced that a groundbreaking new study published in Radiology, the Radiological Society of North America scientific journal, found that the addition of three dimensional (3-D) mammography (breast tomosynthesis) screening technology to a 2-D breast screening exam significantly increased cancer detection while reducing the number of false positives.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now